Compliance Management

WHO Puts a Hold on TB Drugs from India

Mar 23, 2016

Reuters

The World Health Organization has suspended the approval of tuberculosis drugs from India's Svizera Labs, according to a Reuters article. This decision comes following an investigation into quality standards.

The agency reportedly said it put a hold on all TB products made at Svizera's Mumbai site because manufacturing standards and quality management were unreliable. Read the full story